Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
Week In Review: Multitude Out-Licenses Tissue Factor ADC To Adcendo In $1 Billion Deal
August 24, 2024
From TalkMarkets
Big Pharma Stocks: Who’s Leading The Race And Who’s Slipping?
August 20, 2024
From TalkMarkets
Biotech Bull Market: 3 Ways To Play It
August 20, 2024
From TalkMarkets
ProInvestor Insights - August 2024
August 19, 2024
From TalkMarkets
From TalkMarkets
From TalkMarkets
From TalkMarkets
ETFs Where Are They Now?
August 11, 2024
From TalkMarkets
Large Cap Biopharma And Healthcare, A Port In A Storm
August 05, 2024
From TalkMarkets
Divided We Stood, United We Fall
August 04, 2024
From TalkMarkets
From TalkMarkets
From TalkMarkets
From TalkMarkets
Week In Review: Nanjing Triastek Partners With BioNTech In A $1.2 Billion Drug Development Deal
July 27, 2024
From TalkMarkets
Biotech Bull Market Is Intact But SMIDs Are Too Volatile
July 22, 2024
From TalkMarkets
The Market Requires 7 Pairs Of Eyes!
July 21, 2024
From TalkMarkets
Week In Review: Korea's SK Biopharma Acquires Radiopharmaceutical In $571 Million Deal
July 20, 2024
From TalkMarkets
From TalkMarkets
Goldilocks Has Made An Appearance On Wall Street!
July 14, 2024
From TalkMarkets
From TalkMarkets
From TalkMarkets
Tickers
PFE
From TalkMarkets
Market Tries To Read Between The Lines
July 10, 2024
From TalkMarkets
Week In Review: Samsung Biologics Signs $1 Billion Manufacturing Contract With US Biopharma
July 06, 2024
From TalkMarkets
From TalkMarkets
Clinical-Stage BioTech Drug Stocks Declined 13% In June
July 01, 2024
From TalkMarkets
Trading SMID Biotech Stocks In A Volatile Market
July 01, 2024
From TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.